Latest On iCAD, Inc (ICAD):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-16 00:53 EST | News | iCAD Non-GAAP EPS of -$0.14 misses by $0.03, revenue of $5.77M misses by $0.44M | N/A |  |
| 2023-05-16 00:53 EST | News | iCAD, Inc. (ICAD) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-09 14:24 EST | News | iCAD, Hologic gain after update on breast cancer screening | N/A | |
| 2023-04-17 22:33 EST | News | iCAD appoints CFO | N/A | |
| 2023-03-29 13:51 EST | News | iCAD, Inc. (ICAD) Q4 2022 Earnings Call Transcript | N/A | |
About iCAD, Inc (ICAD):
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and automated density assessment solutions, which offers automated, consistent, and standardized reporting tool used for mammogram. It also provides ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities read more...and calcifications in digital breast tomosynthesis; ProFound Panorama, a prototype software product for determining risk factors in interval cancers; and magnetic resonance imaging applications, a tool to detect breast and prostate cancer. In addition, the company offers VeraLook, a solution designed to support the detection of colonic polyps in conjunction with CT Colonography. Further, it provides Xoft Axxent electronic brachytherapy systems for the treatment of early stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices. It serves healthcare centers through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, and resellers. The company also exports its products in Europe, Taiwan, Canada, China, and internationally. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was founded in 1984 and is headquartered in Nashua, New Hampshire.
General
- Name iCAD, Inc
- Symbol ICAD
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryHealth Information Services
- Full Time Employees 113
- Last Split Factor1:5
- Last Split Date2012-08-16
- Fiscal Year EndDecember
- IPO Date1986-12-03
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Technology
- Gic SubIndustryHealth Care Technology
- Web URLhttp://www.icadmed.com
Valuation
- Price/Sales (Trailing 12 Mt.) 13.91
- Price/Book (Most Recent Quarter) 15.12
- Enterprise Value Revenue 14.92
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.25
- Next Year EPS Estimate -$0.03
- Next Quarter EPS Estimate -$0.09
- Profit Margin -59%
- Operating Margin -32%
- Return on Assets -12%
- Return on Equity -99%
- Revenue 29.7 million
- Earnings Per Share -$0.70
- Revenue Per Share $1.34
- Gross Profit 21.73 million
- Quarterly Earnings Growth 11.4%
Highlights
- Market Capitalization 460.99 million
- EBITDA -5863000
- PE Ratio -18.74
- PEG Ratio -0.56
- Analyst Target Price $22.5
- Book Value Per Share $1.30
Share Statistics
- Shares Outstanding 24.92 million
- Shares Float 22.42 million
- % Held by Insiders 821%
- % Held by Institutions 49.98%
- Shares Short 677604
- Shares Short Prior Month 667634
- Short Ratio 3.03
- Short % of Float 3%
- Short % of Shares Outstanding 3%
Technicals
- Beta 1.25
- 52 Week High $21
- 52 Week Low $6.51
- 50 Day Moving Average 17.67
- 200 Day Moving Average 12.69
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
iCAD, Inc (ICAD) Dividend Calendar:
iCAD, Inc (ICAD) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
iCAD, Inc (ICAD) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
iCAD, Inc (ICAD) Chart:
iCAD, Inc (ICAD) News:
Below you will find a list of latest news for iCAD, Inc (ICAD) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
iCAD, Inc (ICAD) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest ICAD Trades:
iCAD, Inc (ICAD) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-06 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-11-05 | 8-K (Current report) | |
| 2020-10-09 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-09 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-10 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-07 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-07 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-08-04 | 8-K (Current report) | |
| 2020-07-16 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-15 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-06 | 8-K (Current report) | |
| 2020-07-02 | 8-K (Current report) | |
| 2020-07-02 | 8-K (Current report) | |
| 2020-07-01 | 4 (Statement of changes in beneficial ownership of securities) | |
iCAD, Inc (ICAD) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of iCAD, Inc (ICAD). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 821%
Institutional Ownership: 4998%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-10-08 | Stacey M Stevens | President | Sell | 15,873.00 | 10.00 | 158,730.00 | 171,788.00 | |
| 2020-10-08 | Stacey M Stevens | President | Buy | 15,873.00 | 2.27 | 36,031.71 | 187,661.00 | |
| 2020-09-09 | ANDY SASSINE | Director | Sell | 10,000.00 | 9.47 | 94,746.00 | 1,314,882.00 | |
| 2020-09-08 | ANDY SASSINE | Director | Sell | 10,000.00 | 9.40 | 93,977.00 | 1,324,882.00 | |
| 2020-09-01 | Stacey M Stevens | President | Sell | 24,127.00 | 10.25 | 247,407.91 | 171,788.00 | |
| 2020-09-01 | Stacey M Stevens | President | Buy | 24,127.00 | 2.27 | 54,768.29 | 195,915.00 | |
| 2020-09-01 | R. Scott Areglado | Chief Financial Officer | Sell | 5,000.00 | 10.49 | 52,431.00 | 36,911.00 | |
| 2020-08-07 | ANDY SASSINE | Director | Sell | 10,000.00 | 10.28 | 102,821.00 | 1,334,882.00 | |
| 2020-08-06 | ANDY SASSINE | Director | Sell | 10,000.00 | 10.31 | 103,079.00 | 1,344,882.00 | |
| 2020-08-05 | Stacey M Stevens | President | Sell | 6,667.00 | 10.07 | 67,146.69 | 171,788.00 | |
| 2020-08-05 | Stacey M Stevens | President | Buy | 6,667.00 | 2.90 | 19,334.30 | 178,455.00 | |
| 2020-07-15 | Stacey M Stevens | President | Sell | 10,000.00 | 10.25 | 102,490.00 | 171,788.00 | |
| 2020-07-15 | Stacey M Stevens | President | Buy | 10,000.00 | 5.10 | 51,000.00 | 181,788.00 | |
| 2020-07-14 | ANDY SASSINE | Director | Sell | 10,000.00 | 9.48 | 94,754.00 | 1,354,882.00 | |
| 2020-07-13 | ANDY SASSINE | Director | Sell | 10,000.00 | 9.53 | 95,300.00 | 1,364,882.00 | |